INDIAGranules India Gains 5% on US FDA Approval for ADHD DrugAmrita ChakravortySeptember 11, 2020September 11, 2020 by Amrita ChakravortySeptember 11, 2020September 11, 20200609 On Friday, Granules India’s shares jumped as much as 5 per cent after it received USFDA approval complex Attention Deficit Hyperactivity Disorder (ADHD) Drug. The Indian pharmaceutical...